| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |